Login to Your Account

Prothena Prices $130M Offering; Janssen to Sell All Holdings

By Catherine Shaffer
Staff Writer

Thursday, October 3, 2013
A public offering of about 5.9 million shares at $22 per share will bring in about $70.8 million in net proceeds for Prothena Corp. plc. Of those, Prothena is offering 3.5 million shares and Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, will offer 2.4 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription